EGFR-targeted therapies in the post-genomic era

MJ Xu, DE Johnson, JR Grandis - Cancer and Metastasis Reviews, 2017 - Springer
Over 90% of head and neck cancers overexpress the epidermal growth factor receptor
(EGFR). In diverse tumor types, EGFR overexpression has been associated with poorer …

EGFR-targeted therapies in the post-genomic era.

MJ Xu, DE Johnson, JR Grandis - Cancer Metastasis Reviews, 2017 - europepmc.org
Over ninety percent of head and neck cancers overexpress the epidermal growth factor
receptor (EGFR). In diverse tumor types, EGFR overexpression has been associated with …

[引用][C] EGFR-targeted therapies in the post-genomic era

MJ Xu, DE Johnson, JR Grandis - Cancer and Metastasis Reviews, 2017 - cir.nii.ac.jp

[HTML][HTML] EGFR-Targeted Therapies in the Post-Genomic Era

MJ Xu, DE Johnson, JR Grandis - Cancer metastasis reviews, 2017 - ncbi.nlm.nih.gov
Over ninety percent of head and neck cancers overexpress the epidermal growth factor
receptor (EGFR). In diverse tumor types, EGFR overexpression has been associated with …

EGFR-targeted therapies in the post-genomic era.

M Xu, D Johnson, J Grandis - Cancer & Metastasis Reviews, 2017 - search.ebscohost.com
Over 90% of head and neck cancers overexpress the epidermal growth factor receptor
(EGFR). In diverse tumor types, EGFR overexpression has been associated with poorer …

EGFR-targeted therapies in the post-genomic era

MJ Xu, DE Johnson, JR Grandis - Cancer metastasis …, 2017 - pubmed.ncbi.nlm.nih.gov
Over 90% of head and neck cancers overexpress the epidermal growth factor receptor
(EGFR). In diverse tumor types, EGFR overexpression has been associated with poorer …

EGFR-targeted therapies in the post-genomic era

MJ Xu, DE Johnson, JR Grandis - Cancer and Metastasis Reviews, 2017 - escholarship.org
Over 90% of head and neck cancers overexpress the epidermal growth factor receptor
(EGFR). In diverse tumor types, EGFR overexpression has been associated with poorer …

EGFR-targeted therapies in the post-genomic era

MJ Xu, DE Johnson, JR Grandis - Cancer and Metastasis …, 2017 - search.proquest.com
Over 90% of head and neck cancers overexpress the epidermal growth factor receptor
(EGFR). In diverse tumor types, EGFR overexpression has been associated with poorer …